Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasms

Blood Cancer J. 2018 Nov 7;8(11):103. doi: 10.1038/s41408-018-0143-y.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Hydroxyurea / pharmacology
  • Hydroxyurea / therapeutic use*
  • Leukocyte Count
  • Myeloid Cells / drug effects*
  • Myeloproliferative Disorders / blood
  • Myeloproliferative Disorders / complications*
  • Myeloproliferative Disorders / drug therapy
  • Recurrence
  • Stroke / blood
  • Stroke / etiology*
  • Stroke / prevention & control*
  • Treatment Outcome

Substances

  • Hydroxyurea